Efficacy Study of Long-term Parenteral Nutrition With SmofKabiven® E in Lung Cancer Patients Under Anticancer Therapy

PHASE4TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

February 28, 2018

Primary Completion Date

April 5, 2019

Study Completion Date

April 5, 2019

Conditions
Cancer-related Malnutrition
Interventions
DRUG

SmofKabiven® E

In the intervention arm, SmofKabiven® E, with or without addition of Suppliven®, Vitalipid® Adult and/or Soluvit®, will be administered in addition to standard of care oral nutrition as per dietary counseling, whereas in the control arm, oral nutrition as per dietary counseling is the primary nutritional support.

Trial Locations (1)

75014

Hôpital Cochin, Paris

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Fresenius Kabi

INDUSTRY